Telum Therapeutics
PrivateLast Round
Series A
Jul 1, 2026
Total Funding Raised
$25.65M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Telum Therapeutics operates in Healthcare & Life Sciences and is based in Spain. Its latest recorded funding round was a Series A round in July 2026.
Telum Therapeutics is a biotechnology company that develops antimicrobial therapies based on engineered phage lytic proteins to treat multidrug-resistant bacterial infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Telum Therapeutics Comparables
Compare Telum Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Obulytix | 82% | |
| Micreos | 78% | |
| Aurobac Therapeutics | 77% |
For institutional investors. Book with your work email.
Telum Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 1, 2026 | ||||
| Seed | Jul 13, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Telum Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| AMR Action Fund | Series A |
| CDTI Innvierte | Series A, Seed |
| Inveready | Series A |
| Clave Capital | Series A, Seed |
| Center for Technological Development and Innovation | Series A |
| Invivo Partners | Series A, Seed |
| Sodena | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 1, 2026
$21M round led by AMR Action Fund.
- Jun 23, 2026
Monthly visitors increased 82% MoM.
For institutional investors. Book with your work email.
Telum Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Telum Therapeutics's valuation, stock price, and market status.
Is Telum Therapeutics a public or private company?
Telum Therapeutics is a private company.
What is the current stock price of Telum Therapeutics?
Telum Therapeutics is a private company, so its shares have no public market price. Caplight tracks Telum Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Telum Therapeutics worth (valuation)?
Valuation information for Telum Therapeutics is not publicly available.
Can I buy Telum Therapeutics stock?
Telum Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Telum Therapeutics's last funding round?
Telum Therapeutics's most recent funding round was Series A on July 1, 2026.
Who are the main investors in Telum Therapeutics?
Key investors in Telum Therapeutics include AMR Action Fund, Invivo Partners.
Will Telum Therapeutics IPO soon?
No public IPO plans have been announced for Telum Therapeutics.
How can I track Telum Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Telum Therapeutics's shares on secondary markets.